EFFICACY AND SAFETY OF SUNITINIB AS FIRST-LINE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: SYSTEMATIC REVIEW

被引：0
|
作者：
Huerfano, C. [1 ]
NinoNino, C. P. [1 ]
Davila, F. [1 ]
Reyes, J. M. [2 ]
Diaz, J. A. [3 ]
机构：
[1] Univ Nacl Colombia, Bogota, Colombia
[2] Pfizer SAS, Bogota, Colombia
[3] Univ Nacl Colombia, Bogota, Colombia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1534
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN201
引用
收藏
页码：A169 / A169
页数：1
相关论文
共 50 条
  • [31] First-line treatment of metastatic renal cell carcinoma
    Bruchbacher, Andreas
    Netsch, Christopher
    Gross, Andreas J. J.
    UROLOGIE, 2023, 62 (08): : 830 - 839
  • [32] Phase I study of dalteparin in combination with sunitinib as first-line treatment in patients with metastatic renal cell carcinoma
    Pill, Roberto
    Pal, Sumanta Kumar
    George, Saby
    Voortman, Jens
    Danchalvijitr, Pongwut
    Adelalye, Remi
    Webb, Nancy
    Poslinski, Diane
    Groman, Adrienne
    Hutson, Alan
    Verheul, Honk M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Bosma, Nicholas A.
    Warkentin, Matthew T.
    Gan, Chun Loo
    Karim, Safiya
    Heng, Daniel Y. C.
    Brenner, Darren R.
    Lee-Ying, Richard M.
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 37 : 14 - 26
  • [34] First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience
    Lalani, Aly-Khan A.
    Li, Haocheng
    Heng, Daniel Y. C.
    Wood, Lori
    Kalirai, Austin
    Bjarnason, Georg A.
    Sim, Hao-Wen
    Kollmannsberger, Christian K.
    Kapoor, Anil
    Hotte, Sebastien J.
    Vanhuyse, Marie
    Czaykowski, Piotr
    Reaume, M. Neil
    Soulieres, Denis
    Venner, Peter
    North, Scott
    Basappa, Naveen S.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (3-4): : 112 - 117
  • [35] Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma
    Czarnecka, Anna M.
    Brodziak, Anna
    Sobczuk, Pawel
    Dendek, Cezary
    Labochka, Dominika
    Korniluk, Jan
    Bartnik, Ewa
    Szczylik, Cezary
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [36] Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma
    Anna M. Czarnecka
    Anna Brodziak
    Pawel Sobczuk
    Cezary Dendek
    Dominika Labochka
    Jan Korniluk
    Ewa Bartnik
    Cezary Szczylik
    Scientific Reports, 9
  • [37] The effect of age on first-line sunitinib treatment in patients with renal cell carcinoma (RCC).
    Coward, J. I. G.
    Larbi, E. D.
    Pandha, H. S.
    Michael, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
    T E Hutson
    R M Bukowski
    B I Rini
    M E Gore
    J M Larkin
    R A Figlin
    C H Barrios
    B Escudier
    X Lin
    K Fly
    B Martell
    E Matczak
    R J Motzer
    British Journal of Cancer, 2014, 110 : 1125 - 1132
  • [39] Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
    Hutson, T. E.
    Bukowski, R. M.
    Rini, B. I.
    Gore, M. E.
    Larkin, J. M.
    Figlin, R. A.
    Barrios, C. H.
    Escudier, B.
    Lin, X.
    Fly, K.
    Martell, B.
    Matczak, E.
    Motzer, R. J.
    BRITISH JOURNAL OF CANCER, 2014, 110 (05) : 1125 - 1132
  • [40] Second-Line Treatment Outcomes After First-Line Sunitinib Therapy in Metastatic Renal Cell Carcinoma
    Chen, Chi-Chang
    Hess, Gregory P.
    Liu, Zhimei
    Gesme, Dean H.
    Agarwala, Sanjiv S.
    Garay, Carlos C.
    Hill, Jerrold W.
    Guo, Amy
    CLINICAL GENITOURINARY CANCER, 2012, 10 (04) : 256 - 261
12345